DIASEM: Correlation of Muscle Ultrasound Measures (2D and 3D) With Biphotonic X-ray Absorptiometry in Oldest Old Patients.

Sponsor
Nantes University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04753450
Collaborator
(none)
30
1
15.7
1.9

Study Details

Study Description

Brief Summary

The sarcopenia diagnosis is based on the muscle mass and on impaired physical performance. The emerging field of ultrasound assessment of muscle mass in older patients is based on 2d parameters with prediction equations for muscle mass. For the moment, validation of prediction equations in older adults with varying function and health is lacking. The study aims to evaluate correlation of muscle mass between 3D muscle mass measurement and DXA, in order to dispense with the prediction equation.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention

Detailed Description

Older patients who agree to participate to the study will undergo 3D ultrasound muscle mass measurement, 2D panoramic mode muscle mass measurement and biphotonic X-ray absorptiometry assessment. Correlation analysis will be done with the different measurement.

Study Design

Study Type:
Observational
Anticipated Enrollment :
30 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Correlation of Muscle Ultrasound Measures (2D and 3D) With Biphotonic X-ray Absorptiometry in Oldest Old Patients.
Actual Study Start Date :
Mar 9, 2021
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Jun 30, 2022

Outcome Measures

Primary Outcome Measures

  1. 3D Correlation between muscle volume measured by 3D ultrasound and standard method : DXA results [1 week]

    Correlation between muscle volume measured by 3D ultrasound and standard method : DXA results

Secondary Outcome Measures

  1. 2D correlation between muscle volume measured by 2D ultrasound and standard method : DXA results [1 week]

    Correlation between muscle volume measured by 2D ultrasound and standard method : DXA results

Eligibility Criteria

Criteria

Ages Eligible for Study:
75 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients over 75 years old

  • Osteoporosis diagnosis confirmed by Dual-energy X-ray Absorptiometry

Exclusion Criteria:
  • Neurocognitive disorders preventing the expression of informed consent

  • Patients who cannot undergo an examination in a static position

  • Lack of a measurement site (muscle resection or amputation)

  • Any state of dehydration or water inflation

  • Patient with legal protection measure

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU de Nantes Nantes France

Sponsors and Collaborators

  • Nantes University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nantes University Hospital
ClinicalTrials.gov Identifier:
NCT04753450
Other Study ID Numbers:
  • RC20_0534
First Posted:
Feb 15, 2021
Last Update Posted:
Jul 16, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 16, 2021